Empirical treatment of sepsis in neutropenic patients-Reference-Cited by-同舟云学术

Empirical treatment of sepsis in neutropenic patients

Published:2001-02 Issue:2 Volume:62 Page:101-103
ISSN:1462-3935
Container-title:Hospital Medicine
language:en
Short-container-title:Hospital Medicine

Author:

Klastersky Jean¹

Affiliation:

1. Service de Médecine et Laboratoire d'Investigation Clinique, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles, rue Héger-Bordet 1, 1000 Bruxelles, Belgium

Publisher

Mark Allen Group

Subject

General Veterinary

Link

http://www.magonlinelibrary.com/doi/pdf/10.12968/hosp.2001.62.2.2089

Reference4 articles.

1. Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

2. The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients

3. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

4. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Allogeneic Neutrophil Transfusion in Improving Survival Rates of Severe Infection Mice;Cell Transplantation;2024-01

2. Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction;Cochrane Database of Systematic Reviews;2016-04-29

3. Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction;Cochrane Database of Systematic Reviews;2015-06-29

4. Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection;Scandinavian Journal of Infectious Diseases;2012-09-19

5. Therapeutic granulocyte transfusions for the treatment of febrile neutropenia in patients with hematologic diseases: a 10-year experience at a single institute;Cytotherapy;2011-04